Genetic Variants in Sulfonylurea Targets Affect Parkinson's Disease Risk: A Two-Sample Mendelian Randomization Study. Aziz NA, Wullner U. Mov Disord 2023 Feb 13. doi: 10.1002/mds.29341.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Aziz NA, Wullner U. Genetic Variants in Sulfonylurea Targets Affect Parkinson's Disease Risk: A Two-Sample Mendelian Randomization Study. Mov Disord 2023 Feb 13. doi: 10.1002/mds.29341.
PMID: 36782054